| __timestamp | Intra-Cellular Therapies, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 9216000000 |
| Thursday, January 1, 2015 | 139626 | 8296000000 |
| Friday, January 1, 2016 | 93831530 | 10044000000 |
| Sunday, January 1, 2017 | 79419009 | 11560000000 |
| Monday, January 1, 2018 | 368673 | 10558000000 |
| Tuesday, January 1, 2019 | 477121 | 9351000000 |
| Wednesday, January 1, 2020 | 1895029 | 8933000000 |
| Friday, January 1, 2021 | 8034589 | 8284000000 |
| Saturday, January 1, 2022 | 20443000 | 7952000000 |
| Sunday, January 1, 2023 | 33745000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Teva Pharmaceutical Industries Limited and Intra-Cellular Therapies, Inc. from 2014 to 2023. Teva, a global leader, consistently reported high costs, peaking in 2017 with a 15% increase from 2014. In contrast, Intra-Cellular Therapies, a smaller player, showed a dramatic rise in costs, with a staggering 1,500% increase from 2015 to 2023. This disparity highlights the scale and operational differences between established giants and emerging innovators. While Teva's costs reflect its expansive operations, Intra-Cellular's rising expenses may indicate growth and increased market penetration. Such insights are invaluable for understanding the financial dynamics and strategic directions of these companies.
Cost Insights: Breaking Down AbbVie Inc. and Intra-Cellular Therapies, Inc.'s Expenses
Amgen Inc. vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Cost Insights: Breaking Down Biogen Inc. and Intra-Cellular Therapies, Inc.'s Expenses
BeiGene, Ltd. vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Grifols, S.A.
Analyzing Cost of Revenue: Intra-Cellular Therapies, Inc. and Cytokinetics, Incorporated
Intra-Cellular Therapies, Inc. vs Alkermes plc: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs BioCryst Pharmaceuticals, Inc.